Search Result

Results for "

cinnamic acid

" in MedChemExpress (MCE) Product Catalog:

By Targets:	5-HT Receptor (1) Adrenergic Receptor (2) Apoptosis (6) Bacterial (9) Biochemical Assay Reagents (2) COX (1) Cytochrome P450 (2) Drug Derivative (5) Drug Intermediate (4) EGFR (2) Endogenous Metabolite (18) Environmental Pollutants (2) Fungal (4) GABA Receptor (1) Glycosidase (3) GSK-3 (2) Histamine Receptor (1) HIV (1) IGF-1R (2) Influenza Virus (2) Insecticide (2) Interleukin Related (4) Isotope-Labeled Compounds (3) Lipoxygenase (1) NO Synthase (1) Nucleoside Antimetabolite/Analog (1) Parasite (4) Proton Pump (1) Reactive Oxygen Species (ROS) (1) Reference Standards (12) Tyrosinase (1)
By Research Areas:	Cancer (17) Endocrinology (2) Infection (20) Inflammation/Immunology (13) Metabolic Disease (9) Neurological Disease (4)

By Targets:

5-HT Receptor (1)

Adrenergic Receptor (2)

Apoptosis (6)

Bacterial (9)

Biochemical Assay Reagents (2)

COX (1)

Cytochrome P450 (2)

Drug Derivative (5)

Drug Intermediate (4)

EGFR (2)

Endogenous Metabolite (18)

Environmental Pollutants (2)

Fungal (4)

GABA Receptor (1)

Glycosidase (3)

GSK-3 (2)

Histamine Receptor (1)

HIV (1)

IGF-1R (2)

Influenza Virus (2)

Insecticide (2)

Interleukin Related (4)

Isotope-Labeled Compounds (3)

Lipoxygenase (1)

NO Synthase (1)

Nucleoside Antimetabolite/Analog (1)

Parasite (4)

Proton Pump (1)

Reactive Oxygen Species (ROS) (1)

Reference Standards (12)

Tyrosinase (1)

By Research Areas:

Cancer (17)

Endocrinology (2)

Infection (20)

Inflammation/Immunology (13)

Metabolic Disease (9)

Neurological Disease (4)

Inhibitors & Agonists

Natural
Products

Isotope-Labeled Compounds

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-N0610A

Cinnamic acid 3 Publications Verification 3-Phenylacrylic acid; β-Phenylacrylic acid	Environmental Pollutants Endogenous Metabolite	Cancer
Cinnamic acid has potential use in cancer intervention, with IC₅₀s of 1-4.5 mM in glioblastoma, melanoma, prostate and lung carcinoma cells.

HY-N0351

p-Coumaric acid 3 Publications Verification trans-4-Hydroxycinnamic acid	Endogenous Metabolite Bacterial Apoptosis	Inflammation/Immunology Cancer
p-Coumaric acid (trans-4-Hydroxycinnamic acid) is an isomer of cinnamic acid with oral activity. p-Coumaric acid inhibits cell proliferation and promotes apoptosis. p-Coumaric acid has antibacterial, anti-inflammatory, antioxidant and anti-tumor activities .

HY-N0610

*Trans-Cinnamic* acid** 2 Publications Verification Trans-3-Phenylacrylic acid	Environmental Pollutants Endogenous Metabolite Bacterial	Infection Cancer
trans-Cinnamic acid is a natural antimicrobial, with minimal inhibitory concentration (MIC) of 250 μg/mL against fish pathogen A. sobria, SY-AS1 .

HY-77641

Cinnamoylglycine	Endogenous Metabolite	Metabolic Disease
Cinnamoylglycine is a human urinary metabolite and PPG analog. Cinnamoylglycine is a conjugate of cinnamic acid and glycine. Cinnamoylglycine is used as a urine marker. Cinnamoylglycine can be used in adipogenic differentiation studies .

HY-N0761

Isoferulic acid 3 Publications Verification 3-Hydroxy-4-methoxycinnamic acid	Adrenergic Receptor Influenza Virus	Infection Metabolic Disease Inflammation/Immunology Endocrinology
Isoferulic acid (3-Hydroxy-4-methoxycinnamic acid) is an orally active cinnamic acid derivative. Isoferulic acid exhibits hypoglycemic, antiviral, and antioxidant activities. Isoferulic acid can also inhibit fructose- and glucose-mediated protein glycation. Isoferulic acid can be used in the research of diseases such as diabetes .

HY-41404

Piperonylic acid 2H-1,3-benzodioxole-5-carboxylic acid	Cytochrome P450 Interleukin Related EGFR IGF-1R	Infection Others Cancer
Piperonylic acid is a natural molecule bearing a methylenedioxy function that closely mimics the structure of trans-cinnamic acid. Piperonylic Acid is a selective, mechanism-based inactivator of the trans-cinnamate 4-Hydroxylase. Piperonylic acid has anticancer, antioxidant and antibacterial activities .

HY-N0610R

*trans-Cinnamic* acid (Standard)** Trans-3-Phenylacrylic acid (Standard)	Reference Standards Bacterial Endogenous Metabolite	Infection Cancer
trans-Cinnamic acid (Standard) is the analytical standard of trans-Cinnamic acid. This product is intended for research and analytical applications. trans-Cinnamic acid is a natural antimicrobial, with minimal inhibitory concentration (MIC) of 250 μg/mL against fish pathogen A. sobria, SY-AS1 .

HY-N0351S1

p-Coumaric acid-d6 1 Publications Verification trans-4-Hydroxycinnamic acid-d₆	Endogenous Metabolite	Cancer
p-Coumaric acid-d₆ is the deuterium labeled p-Coumaric acid (HY-N0351). p-Coumaric acid is the abundant isomer of cinnamic acid which has antitumor and anti-mutagenic activities .

HY-N0351R

p-Coumaric acid (Standard) trans-4-Hydroxycinnamic acid (Standard)	Reference Standards Endogenous Metabolite Bacterial Apoptosis	Inflammation/Immunology Cancer
p-Coumaric acid (Standard) is the analytical standard of p-Coumaric acid. This product is intended for research and analytical applications. p-Coumaric acid (trans-4-Hydroxycinnamic acid) is an isomer of cinnamic acid with oral activity. p-Coumaric acid inhibits cell proliferation and promotes apoptosis. p-Coumaric acid has antibacterial, anti-inflammatory, antioxidant and anti-tumor activities .

HY-W050162

(E)-3,4,5-Trimethoxycinnamic acid 1 Publications Verification TMCA	GABA Receptor 5-HT Receptor	Neurological Disease
(E)-3,4,5-Trimethoxycinnamic acid (TMCA) is a cinnamic acid substituted by multi-methoxy groups. (E)-3,4,5-Trimethoxycinnamic acid is an orally active and potent GABA_A/BZ receptor agonist. (E)-3,4,5-Trimethoxycinnamic exhibits favourable binding affinity to 5-HT_2C and 5-HT_1A receptor, with IC₅₀ values of 2.5 and 7.6 μM, respectively. (E)-3,4,5-Trimethoxycinnamic acid shows anticonvulsant and sedative activity. (E)-3,4,5-Trimethoxycinnamic acid can be used for the research of insomnia, headache and epilepsy .

HY-W015399

4-Methylcinnamic acid	Fungal	Infection
4-Methylcinnamic acid is a cinnamic acid derivative with antifungal activity. 4-Methylcinnamic acid can overcome the tolerance of glutathione reductase mutants to 4-Methoxycinnamic acid (HY-N1387). When 4-Methylcinnamic acid is used in combination with traditional antifungal agents, it can reduce their minimum inhibitory concentrations. 4-Methylcinnamic acid can act as an intervention catalyst to enhance the efficacy of traditional antifungal agents and has application potential in targeting fungal cell wall disruption and controlling drug-resistant fungi .

HY-I0008

*3-(Trifluoromethyl)cinnamic* acid**	Biochemical Assay Reagents	Neurological Disease Inflammation/Immunology
3-(Trifluoromethyl)cinnamic acid is a cinnamic acid derivative which can be extracted from Polygalae Radix. 3-(Trifluoromethyl)cinnamic acid exerts hepatoprotective, anti-gastric lesions and anti-neurodegenerative effects and can be used in chemical synthesis .

HY-114771

α-Truxillic acid	Drug Intermediate	Inflammation/Immunology
α-Truxillic acid is form by the dimerization of two molecules of α-trans-cinnamic acid, with anti-inflammatory activities. α-Truxillic acid has no analgesic activity, but its derivatives bound to camphor fragments exhibit significant activity in the peripheral analgesic model (writhing test) .

HY-N0351S

p-Coumaric acid-13C3	Endogenous Metabolite	Cancer
p-Coumaric acid- ¹³C₃ is the ¹³C-labeled p-Coumaric acid. p-Coumaric acid is the abundant isomer of cinnamic acid which has antitumor and anti-mutagenic activities.

HY-W102375

4-Acetoxycinnamic acid	Drug Intermediate	Inflammation/Immunology
4-Acetoxycinnamic acid is an acetate ester obtained by the formal condensation of the hydroxy group of trans-4-coumaric acid with acetic acid. 4-Acetoxycinnamic acid is a member of cinnamic acids and a member of phenyl acetates. 4-Acetoxycinnamic acid derives from a trans-4-coumaric acid .

HY-N0610S1

*trans-Cinnamic* acid-d7** trans-3-Phenylacrylic acid-d₇	Bacterial Endogenous Metabolite	Infection
trans-Cinnamic acid-d₇ is the deuterium labeled trans-Cinnamic acid . trans-Cinnamic acid is a natural antimicrobial, with minimal inhibitory concentration (MIC) of 250 μg/mL against fish pathogen A. sobria, SY-AS1 .

HY-N0610AS

Cinnamic acid-d6 3-Phenylacrylic acid-d₆; β-Phenylacrylic acid-d₆	Endogenous Metabolite	Cancer
Cinnamic acid-d₆ is the deuterium labeled Cinnamic acid. Cinnamic acid has potential use in cancer intervention, with IC50s of 1-4.5 mM in glioblastoma, melanoma, prostate and lung carcinoma cells.

HY-N0610AS2

Cinnamic acid-13C3 3-Phenylacrylic acid-¹³C₃; β-Phenylacrylic acid-¹³C₃	Isotope-Labeled Compounds Endogenous Metabolite	Cancer
Cinnamic acid- ¹³C₃ (3-Phenylacrylic acid- ¹³C₃) is the ¹³C labeled Cinnamic acid (HY-N0610A). Cinnamic acid has potential use in cancer intervention, with IC₅₀s of 1-4.5 mM in glioblastoma, melanoma, prostate and lung carcinoma cells .

HY-N0351A

cis-p-Coumaric acid cis-4-Hydroxycinnamic acid	Apoptosis	Metabolic Disease
cis-p-Coumaric acid (cis-4-Hydroxycinnamic acid) is the cis-form of p-Coumaric acid (HY-N0351), which is higher in viable seeds of groundnuts than in non-viable ones. p-Coumaric acid is an isomer of cinnamic acid with oral activity. p-Coumaric acid inhibits cell proliferation and promotes Apoptosis .

HY-N2492

(E)-Methyl 4-coumarate Methyl trans-p-coumarate	Apoptosis Interleukin Related GSK-3 Parasite	Infection Cancer
(E)-Methyl 4-coumarate (Methyl 4-hydroxycinnamate) is a phenolic compound and derivative of Cinnamic acid (HY-N0610A). (E)-Methyl 4-coumarate can be found in several plants, such as the leaves of Allium cepa and Morinda citrifolia L. (E)-Methyl 4-coumarate, when combined with Carnosic acid (HY-N0644), induces Apoptosis. (E)-Methyl 4-coumarate inhibits GSK3β activity and modulates inflammatory cytokine levels (increasing IL-10 and decreasing IL-4). (E)-Methyl 4-coumarate combined with Carnosic acid exhibits anticancer effects against acute myeloid leukemia. (E)-Methyl 4-coumarate ameliorates Plasmodium berghei NK65 infection .

HY-W067479

(E)-Cinnamamide	Insecticide	Others
(E)-Cinnamamide, the less active isomer of Cinnamamide. Cinnamamide, a derivative of the plant secondary compound Cinnamic acid. Cinnamamide is effective as a non-lethal chemical repellent suitable for reducing avian pest damage .

HY-77641S

Cinnamoylglycine-d2	Isotope-Labeled Compounds Endogenous Metabolite	Metabolic Disease
Cinnamoylglycine-d₂ is the deuterium labeled Cinnamoylglycine. Cinnamoylglycine is a glycine conjugate of cinnamic acid and a urinary metabolite in human. Cinnamoylglycine is used as a potential urinary biomarker indicating intact or disrupted colonization resistance during and after antibiotic treatment .

HY-Y0729

4-Chlorocinnamic acid 1 Publications Verification	Tyrosinase Bacterial Fungal Drug Derivative	Infection Neurological Disease
4-Chlorocinnamic acid is a derivative of Cinnamic acid (HY-N0610A). 4-Chlorocinnamic acid inhibits the monophenolase and diphenolase activities of mushroom tyrosinase with IC₅₀ values of 0.477 mM and 0.229 mM, respectively. 4-Chlorocinnamic acid inhibits the mycelial growth of Colletotrichum gloeosporioides. 4-Chlorocinnamic acid exhibits anticonvulsant activity against acute epilepsy induced by pentylenetetrazol .

HY-75424A

*2-(Trifluoromethyl)cinnamic* acid**	Proton Pump	Inflammation/Immunology
2-(Trifluoromethyl)cinnamic acid is a cinnamic acid derivative that inhibits the proton pump (H ⁺/K ⁺-ATPase), thereby reducing gastric acid secretion. 2-(Trifluoromethyl)cinnamic acid also improves delayed gastric emptying and can be used in research on gastric diseases such as acute gastritis and gastric ulcers .

HY-W019715

*trans-4-(Trifluoromethyl)cinnamic* acid**	Drug Derivative	Others
trans-4-(Trifluoromethyl)cinnamic acid is a Phenylpropanoids product that can be isolated from the barks of Cinnamomum cassia Presl .

HY-W015399R

4-Methylcinnamic acid (Standard)	Reference Standards Fungal	Infection
4-Methylcinnamic acid, a Cinnamic acid analog, can be used as a intervention catalyst for overcoming antifungal tolerance. 4-Methylcinnamic acid can improve the potency of cell wall-disrupting agents .

HY-P2951

Phenylalanine ammonia-lyase	Biochemical Assay Reagents	Metabolic Disease
Phenylalanine ammonia-lyase is a non-mammalian enzyme converting phenylalanine into trans-cinnamic acid and ammonia. Phenylalanine ammonia-lyase can be used in the research of phenylketonuria .

HY-130762

Cinnamic acid sodium	Apoptosis	Neurological Disease Inflammation/Immunology
Cinnamic acid sodium is a orally active naturally occurring aromatic fatty acid of low toxicity. Cinnamic acid sodium shows neuroprotective and anti-inflammatory effects .

HY-N0610AR

Cinnamic acid (Standard) 3-Phenylacrylic acid (Standard); β-Phenylacrylic acid (Standard)	Reference Standards Endogenous Metabolite	Cancer
Cinnamic acid (Standard) is the analytical standard of Cinnamic acid. This product is intended for research and analytical applications. Cinnamic acid has potential use in cancer intervention, with IC50s of 1-4.5 mM in glioblastoma, melanoma, prostate and lung carcinoma cells.

HY-W068783

*(E)-3,4-(Methylenedioxy)cinnamic* acid** (E)-Piperonylprop-2-enoic acid	Endogenous Metabolite	Others
(E)-3,4-(Methylenedioxy)cinnamic acid is a cinnamic acid derivative obtained from the stem bark of Brombya platynema .

HY-N12538

*trans-Cinnamic* anhydride**	Parasite	Infection
trans-Cinnamic anhydride is a Parasite inhibitor tnat can be isolated from Cinnamomum zeylanicum and exhibits moderate activity against Plasmodium falciparum .

HY-N0610S

*trans-Cinnamic* acid-d5** trans-3-Phenylacrylic acid-d₅	Bacterial Endogenous Metabolite	Infection
trans-Cinnamic acid-d₅ is the deuterium labeled trans-Cinnamic acid . trans-Cinnamic acid is a natural antimicrobial, with minimal inhibitory concentration (MIC) of 250 μg/mL against fish pathogen A. sobria, SY-AS1 .

HY-N15722

*9-O-β-D-Glucopyranosyl-3,4-dimethoxy-cinnamic* acid**	Reactive Oxygen Species (ROS)	Inflammation/Immunology
9-O-β-D-Glucopyranosyl-3,4-dimethoxy-cinnamic acid is an orally active phenylpropanoid glycoside found in Microlepia pilosissima, acting as an antioxidant. 9-O-β-D-Glucopyranosyl-3,4-dimethoxy-cinnamic acid shows a DPPH radical scavenging activity with an ED₅₀ value of 38.1 μM. 9-O-β-D-Glucopyranosyl-3,4-dimethoxy-cinnamic acid is promising for research of oxidative stress-related diseases such as inflammation and liver injury .

HY-168058

WXC-25	Glycosidase
WXC-25 is an inhibitor of α-glucosidase with an IC₅₀ value of 2.02 μM .

HY-163297

Antifungal agent 90	Fungal	Infection
Antifungal agent 90 (Compound 7n) is an antifungal agent that inhibits ergosterol biosynthesis. Antifungal agent 90 showed excellent antifungal activity against Valsa mali and Botrytis cinerea with EC₅₀ values respectively. 4.26 and 1.41 μg/mL .

HY-163188

COX-2/LOX-IN-2	COX Lipoxygenase	Inflammation/Immunology
COX-2/LOX-IN-2 (compound 6) is a dual inhibitor of COX-2/LOX with IC₅₀s of 7.0 μM and 27.5 μM, respectively. COX-2/LOX-IN-2 has antioxidant activity and has the potential to be used in the development of nonsteroidal anti-inflammatory drugs (tNSAIDs) .

HY-77641R

Cinnamoylglycine (Standard)	Reference Standards Endogenous Metabolite	Metabolic Disease
Cinnamoylglycine (Standard) is the analytical standard of Cinnamoylglycine. This product is intended for research and analytical applications. Cinnamoylglycine is a glycine conjugate of cinnamic acid and a urinary metabolite in human. Cinnamoylglycine is used as a potential urinary biomarker indicating intact or disrupted colonization resistance during and after antibiotic treatment .

HY-41404R

Piperonylic acid (Standard) 2H-1,3-benzodioxole-5-carboxylic acid (Standard)	Cytochrome P450 Interleukin Related EGFR IGF-1R Reference Standards	Infection Others Cancer
Piperonylic acid (Standard) is the analytical standard of Piperonylic acid. This product is intended for research and analytical applications. Piperonylic acid is a natural molecule bearing a methylenedioxy function that closely mimics the structure of trans-cinnamic acid. Piperonylic Acid is a selective, mechanism-based inactivator of the trans-cinnamate 4-Hydroxylase. Piperonylic acid has anticancer, antioxidant and antibacterial activities .

HY-N0761R

Isoferulic acid (Standard) 3-Hydroxy-4-methoxycinnamic acid (Standard)	Reference Standards Adrenergic Receptor Influenza Virus	Infection Metabolic Disease Inflammation/Immunology Endocrinology
Isoferulic acid (Standard) (3-Hydroxy-4-methoxycinnamic acid (Standard)) is the analytical standard of Isoferulic acid (HY-N0761). This product is intended for research and analytical applications. Isoferulic acid (3-Hydroxy-4-methoxycinnamic acid) is an orally active cinnamic acid derivative. Isoferulic acid exhibits hypoglycemic, antiviral, and antioxidant activities. Isoferulic acid can also inhibit fructose- and glucose-mediated protein glycation. Isoferulic acid can be used in the research of diseases such as diabetes .

HY-N9251R

Cyclo(Ile-Ala) (Standard)	Reference Standards Others	Others
Isoferulic acid (Standard) is the analytical standard of Isoferulic acid. This product is intended for research and analytical applications. Isoferulic acid (3-Hydroxy-4-methoxycinnamic acid) is a cinnamic acid derivative that has antidiabetic activity. Isoferulic acid binds to and activates α1-adrenergic receptors (IC50=1.4 µM) to enhance secretion of β-endorphin (EC50=52.2 nM) and increase glucose use. Isoferulic acid also has anti-influenza virus activities.

HY-N2492R

(E)-Methyl 4-coumarate (Standard) Methyl trans-p-coumarate (Standard)	Reference Standards Apoptosis Parasite Interleukin Related GSK-3	Infection Cancer
(E)-Methyl 4-coumarate (Standard) is the analytical standard of (E)-Methyl 4-coumarate (HY-N2492). This product is intended for research and analytical applications. (E)-Methyl 4-coumarate (Methyl 4-hydroxycinnamate) is a phenolic compound and derivative of Cinnamic acid (HY-N0610A). (E)-Methyl 4-coumarate can be found in several plants, such as the leaves of Allium cepa and Morinda citrifolia L. (E)-Methyl 4-coumarate, when combined with Carnosic acid (HY-N0644), induces Apoptosis. (E)-Methyl 4-coumarate inhibits GSK3β activity and modulates inflammatory cytokine levels (increasing IL-10 and decreasing IL-4). (E)-Methyl 4-coumarate combined with Carnosic acid exhibits anticancer effects against acute myeloid leukemia. (E)-Methyl 4-coumarate ameliorates Plasmodium berghei NK65 infection .

HY-W019715R

*trans-4-(Trifluoromethyl)cinnamic* acid (Standard)**	Others Reference Standards	Others
trans-4-(Trifluoromethyl)cinnamic acid (Standard) is the analytical standard of trans-4-(Trifluoromethyl)cinnamic acid (HY-W019715). This product is intended for research and analytical applications. trans-4-(Trifluoromethyl)cinnamic acid is a Phenylpropanoids product that can be isolated from the barks of Cinnamomum cassia Presl .

HY-W739223

*Trans-Cinnamic* acid-d6** Trans-3-Phenylacrylic acid-d₆	Isotope-Labeled Compounds Bacterial Endogenous Metabolite	Infection Cancer
Trans-Cinnamic acid-d₆ (Trans-3-Phenylacrylic acid-d₆) is the deuterium labeled Trans-Cinnamic acid (HY-N0610). trans-Cinnamic acid is a natural antimicrobial, with minimal inhibitory concentration (MIC) of 250 μg/mL against fish pathogen A. sobria, SY-AS1 .

HY-N17566

Eukovoside	Bacterial Histamine Receptor	Infection Inflammation/Immunology
Eukovoside is a cinnamic acid derivative found in Euphrasia regelii with anti-inflammatory, antioxidant, antibacterial, antiallergic, and antihistamine activity. Eukovoside can be used for the research of hyperglycemic diseases, eye inflammation, upper respiratory passages inflammation, hay fever, conjunctivitis, colds, influenza, sinusitis .

HY-N7423A

(E)-Methyl isoferulate (E)-Isoferulic acid methyl ester	Drug Derivative NO Synthase Endogenous Metabolite	Infection Cancer
(E)-Methyl isoferulate ((E)-Isoferulic acid methyl ester) (Compound 8) is a derivative of Cinnamic acid (HY-N0610A) and NO inhibitor, with an IC₅₀ > 100 μM against nitric oxide production. (E)-Methyl isoferulate is isolable from the solid cultures of the edible mushroom Neolentinus lepideus. (E)-Methyl isoferulate exerts mild anticancer effects against liver cancer and leukemia .

HY-N17977

Lansiumamide A	Drug Derivative	Others
Lansiumamide A is a cinnamamide derivative found in the seeds of Clausena lansium .

HY-W016623

3-Methoxycinnamic acid	Drug Intermediate	Cancer
3-Methoxycinnamic acid is a key intermediate in the synthesis of phosphatidylcholine containing cinnamic acid (HY-N0610A). 3-Methoxycinnamic acid exhibits anti-proliferative properties against cancer cells .

HY-N19933

cis-3-O-Hydroxycinnamoyl-ursolic acid	Glycosidase
cis-3-O-Hydroxycinnamoyl-ursolic acid is a cis-cinnamic acid ester derivative. cis-3-O-Hydroxycinnamoyl-ursolic acid exhibits no α-glucosidase inhibitory activity .

HY-180639

trans-2,3-Dihydroxycinnamate	Nucleoside Antimetabolite/Analog	Metabolic Disease
trans-2,3-Dihydroxycinnamate, a derivative of Cinnamic acid (HY-N0610A), is a metabolite of cannabidiol. trans-2,3-Dihydroxycinnamate possesses antioxidizing activity .

HY-N18199

rel-Bornyl cinnamate	Parasite	Infection
rel-Bornyl cinnamate is an anti-schistosomal agent. rel-Bornyl cinnamate induces round, dark morphological changes, followed by degeneration in Schistosoma mansoni schistosomula. rel-Bornyl cinnamate can be used for the research of schistosomiasis .

Cat. No.	Product Name	Category	Target	Chemical Structure